Home Cart Sign in  
Chemical Structure| 388592-44-7 Chemical Structure| 388592-44-7

Structure of CK-869
CAS No.: 388592-44-7

Chemical Structure| 388592-44-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

CK869 is an inhibitor of actin polymerization, it functions by inhibiting the actin-related protein 2/3 (Arp2/3) complex and reduced cell motility rate and rearrangement of F-actin in M-1 cells.

Synonyms: CK-0157869

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of CK-869

CAS No. :388592-44-7
Formula : C17H16BrNO3S
M.W : 394.28
SMILES Code : O=C1N(C2=CC=C(OC)C=C2OC)C(C3=CC=CC(Br)=C3)SC1
Synonyms :
CK-0157869
MDL No. :MFCD01844129
InChI Key :MVWNPZYLNLATCH-UHFFFAOYSA-N
Pubchem ID :3574452

Safety of CK-869

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H302-H361-H372-H410
Precautionary Statements:P201-P264-P280-P301+P330+P331-P312
Class:9
UN#:3077
Packing Group:

Related Pathways of CK-869

cytoskeleton

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
U2OS cells 25 μM 4 h Observed changes in adhesion assembly dynamics, finding that Arp2/3 inhibition significantly reduces nascent adhesion assembly PLoS One. 2014 Jun 26;9(6):e100943
MCF10A epithelial cells 12.5 μM, 25 μM, 50 μM 4-10 h Inhibition of Arp2/3 activity disrupts lamellipodium formation, leading to impaired directional cell migration PLoS One. 2014 Jun 26;9(6):e100943
MDA-MB-468 cells 50 μM 24 h Combination of CK869 and EIPA significantly reduced ACE2 expression and inhibited ACE2-dependent viral entry J Virus Erad. 2022 Dec;8(4):100307
Calu-3 cells 50 μM 24 h Combination of CK869 and EIPA significantly reduced ACE2 expression and inhibited ACE2-dependent viral entry J Virus Erad. 2022 Dec;8(4):100307
Murine kidney collecting duct M-1 cells 200 μM 2 h To investigate the effects of CK-869 on actin cytoskeleton remodeling in M-1 cells. Results showed that CK-869 treatment led to F-actin reorganization and significantly affected cell motility rate. Cell Tissue Res. 2013 Dec;354(3):783-92
bone marrow-derived macrophages 100 µM Study the effects of CK-869 and CK-666 on macrophage morphology and phagocytosis. Results showed that CK-869 significantly altered macrophage morphology and reduced phagocytosis, while CK-666 had no significant effect. EMBO Rep. 2024 Aug;25(8):3221-3239
HeLa cells 50, 100, 200, 300 µM 60 min Investigate the inhibitory effects of CK-869 and CK-666 on virus-induced actin assembly. Results showed that CK-869 nearly completely inhibited virus-induced actin assembly, while CK-666 only partially inhibited even at 300 µM. EMBO Rep. 2024 Aug;25(8):3221-3239

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.54mL

0.51mL

0.25mL

12.68mL

2.54mL

1.27mL

25.36mL

5.07mL

2.54mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories